Development of new compositions for dust control in the mining and mineral transportation industry

Dust control in summer and winter periods is a topical problem associated with conducting open pit mining operations; however, at negative temperatures the additional requirements are imposed on dust suppressants. Preventive compositions are proposed, in which light and heavy gas oils, obtained from catalytic cracking and delayed coking, are used as base components. Involvement of heavy fractions allows to increase the flash point, thereby reducing the flammability of dust suppressant, improve its adhesion properties by increasing the content of polyaromatic hydrocarbons and reduce the cost of the final product. In order to improve low-temperature and adsorption properties of developed dust suppressants, heavy oil residues (cracking residue and tar) are included in their composition in various concentrations: 2-10 wt.%. Alternative compositions of dust suppressants, obtained by water emulsification of vinylated alkyd oligomer, are developed; the ability of this dispersion to form strong films on dusty surfaces is examined. The efficiency of using aqueous solution of vinylated alkyd oligomer as a summer dust suppressant is demonstrated. The results of this study include the development of new preventive compositions with improved low-temperature properties and confirmation of the theoretical part of the study by the results of performance tests on a laboratory facility.Alternative compositions of dust suppressors have been developed, which were obtained by emulsifying a vinyl alkyd oligomer (VAO) in water; the ability of this dispersion to form strong films on dusty surfaces has been studied. The efficiency of using an aqueous solution of vinyl alkyd oligomer in the summer period as a dust suppressant is shown. The results of this study are the development of new prophylactic formulations with improved low-temperature properties and confirmation of the theoretical part of the study by the results of tests of operational characteristics in a laboratory facility

Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18–60 and 60+ Age Cohorts

We present the results of a randomized, double-blind, placebo-controlled, multi-center clinical trial phase I/II of the tolerability, safety, and immunogenicity of the inactivated whole virion concentrated purified coronavirus vaccine CoviVac in volunteers aged 18–60 and open multi-center comparative phase IIb clinical trial in volunteers aged 60 years and older. The safety of the vaccine was assessed in 400 volunteers in the 18–60 age cohort who received two doses of the vaccine (n = 300) or placebo (n = 100) and in 200 volunteers in 60+ age cohort all of whom received three doses of the vaccine. The studied vaccine has shown good tolerability and safety. No deaths, serious adverse events (AEs), or other significant AEs related to vaccination have been detected. The most common AE in vaccinated participants was pain at the injection site (p p 1:256, the rate of fourfold increase in nAB levels was below 45%; the participants who were seropositive at screening of the 2nd vaccination did not lead to a significant increase in nAB titers. In conclusion, inactivated vaccine CoviVac has shown good tolerability and safety, with over 85% NT seroconversion rates after complete vaccination course in participants who were seronegative at screening in both age groups: 18–60 and 60+. In participants who were seropositive at screening and had nAB titers below 1:256, a single vaccination led to a fourfold increase in nAB levels in 85.2% of cases. These findings indicate that CoviVac can be successfully used both for primary vaccination in a two-dose regimen and for booster vaccination as a single dose in individuals with reduced neutralizing antibody levels